| 【Company Research】CMGE Technology (302 HK) – Eyes on strong pipeline in FY23E |
| 【Company Research】CR Beer (291 HK) – An in-line 2H22; our top pick among China F&B names |
| 【Company Research】Meituan (3690 HK) – Embracing tougher fight ahead |
| 【Company Research】L.K. Technology (558 HK) – Key takeaways from plant visit in Shenzhen |
| 【Company Research】WuXi Biologics (2269 HK) – Stronger competency for a brighter future |
| 【Company Research】AAC Tech (2018 HK) – 4Q22 slightly below; recovery remains bumpy |
| 【Company Research】Zhihu (ZH US) – Vocational training & AIGC as LT driver |
| 【Company Research】Baozun (BZUN US) – Reorganizing to capture LT opportunities |
| 【Sector Research】China Internet – February online game market recap |
| 【Company Research】CSPC Pharmaceutical (1093 HK) – mRNA platform verified with product approval |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
